Urodynamic Devices

Urodynamic Devices Market Outlook

The global urodynamic devices market is projected to reach approximately USD 1.9 billion by 2025, with a compound annual growth rate (CAGR) of around 6.8% during the forecast period from 2025 to 2035. This growth trajectory is primarily fueled by the rising prevalence of urinary disorders, increasing awareness regarding urodynamic testing, and advancements in diagnostic technologies. Furthermore, the aging population and the associated rise in conditions such as urinary incontinence and benign prostatic hyperplasia are set to significantly bolster the demand for urodynamic devices. The integration of innovative technologies that enhance the accuracy and comfort of urodynamic testing is also a key factor driving market growth. As healthcare professionals increasingly recognize the importance of urodynamic studies in diagnosing and managing urinary conditions, the market is expected to witness substantial expansion.

Growth Factor of the Market

Several factors contribute to the robust growth of the urodynamic devices market. Firstly, the increasing prevalence of urinary incontinence, which affects millions of people worldwide, is a significant driver. As awareness regarding the condition grows, more individuals are seeking diagnosis and treatment options, thereby amplifying the demand for urodynamic testing devices. Additionally, technological advancements, such as the development of portable and user-friendly urodynamic devices, are facilitating easier and more extensive testing. These innovations not only improve patient comfort but also expand the accessibility of urodynamic assessments. Furthermore, the surge in healthcare expenditure, particularly in developing regions, is enhancing the ability of healthcare facilities to invest in advanced diagnostic equipment. Lastly, the growing emphasis on personalized medicine is prompting clinicians to employ urodynamic studies to tailor treatment plans for patients, further stimulating market growth.

Key Highlights of the Market

• The global urodynamic devices market is expected to exhibit significant growth, driven by rising urinary disorders.
• Technological advancements are enhancing the accuracy and efficiency of urodynamic testing.
• There is increasing awareness among healthcare professionals regarding the importance of urodynamic studies for accurate diagnosis.
• The aging population is contributing to a higher incidence of urinary-related conditions, boosting the demand for devices.
• Investment in healthcare infrastructure in emerging economies is creating new opportunities for market players.

By Product Type

Uroflowmetry Equipment:

Uroflowmetry equipment is a vital component of the urodynamic devices market, primarily used to measure the flow rate of urine. The data gathered through uroflowmetry aids physicians in diagnosing conditions such as urinary obstruction or incontinence. The growing prevalence of these conditions, alongside a rising number of urological procedures, has significantly increased the demand for uroflowmetry equipment. This segment is witnessing technological advancements, including the integration of digital technologies that enhance the accuracy and user-friendliness of the devices. Furthermore, as outpatient procedures become more common, the importance of uroflowmetry in clinical settings is on the rise, contributing to the segment's growth within the overall market.

Cystometry Equipment:

Cystometry equipment plays a crucial role in assessing bladder function and diagnosing urinary disorders. This equipment is designed to measure bladder pressure during the filling phase and assess the bladder's capacity and compliance. As urinary incontinence and other related disorders become more prevalent, the demand for cystometry equipment is surging. Technological advancements in this area have led to the development of more sophisticated devices that provide real-time data and enhance patient comfort. Additionally, the growing trend of minimally invasive procedures in urology is driving the adoption of cystometry equipment, as it is essential for evaluating bladder functionality before and after surgical interventions.

Ambulatory Urodynamic Systems:

Ambulatory urodynamic systems are designed to provide continuous monitoring of bladder activity in patients’ natural environments, thereby offering a more comprehensive assessment of urodynamic functions. These systems have gained popularity due to their ability to deliver more realistic data compared to traditional stationary systems. With increasing demands for patient-centered care and convenience, ambulatory urodynamic systems are becoming an essential tool in urology practices. The growing focus on outpatient care and the need for effective management of urinary disorders in non-hospital settings is further propelling the growth of this segment within the urodynamic devices market.

Electromyography Devices:

Electromyography devices are crucial in assessing the neurological control of bladder function by measuring the electrical activity of the pelvic floor muscles. These devices are increasingly being used in conjunction with other urodynamic tests to provide a comprehensive understanding of bladder function. The rising incidence of neurological disorders that affect bladder control is driving the demand for electromyography devices. Moreover, advancements in technology, such as portable devices that can easily be used in various clinical settings, are enhancing the adoption of electromyography for urodynamic assessments. As clinicians recognize the value of combined assessments for effective diagnosis and treatment planning, the segment is likely to experience substantial growth.

Video Urodynamic Systems:

Video urodynamic systems are instrumental in providing a visual representation of the bladder and urethra during urodynamic tests. This advanced technology allows for detailed assessments of complex urinary disorders, making it a vital tool in urology practices. The increasing complexity of urological conditions, coupled with a growing preference for minimally invasive procedures, is driving demand for video urodynamic systems. These systems enhance diagnostic accuracy and provide valuable insights for treatment planning. As healthcare facilities continue to adopt advanced diagnostic tools to improve patient outcomes, the video urodynamic systems segment is poised for significant growth in the coming years.

By Application

Urinary Incontinence:

Urinary incontinence remains one of the primary applications driving the urodynamic devices market. This condition affects both men and women, particularly among the aging population, leading to significant physical and psychological impacts. Urodynamic assessments are essential for determining the cause and severity of urinary incontinence, facilitating appropriate treatment plans. The rising awareness of available treatments and the need for effective management strategies are propelling the demand for urodynamic devices in this segment. As the healthcare industry increasingly prioritizes patient-centered care, the emphasis on accurate diagnosis and tailored treatment for urinary incontinence continues to drive market growth.

Neurological Diseases:

The application of urodynamic devices in the assessment of neurological diseases is gaining momentum as the linkage between bladder dysfunction and neurological conditions is recognized. Diseases such as multiple sclerosis, Parkinson’s disease, and spinal cord injuries can significantly affect bladder control and function. Urodynamic studies provide essential insights into the bladder dynamics in these patients, guiding clinicians in developing effective management strategies. The rising prevalence of neurological disorders is fostering the demand for specialized urodynamic assessments, thereby enhancing the growth of this application within the overall market.

Urological Cancer:

Urological cancer is another critical application driving the urodynamic devices market, as conditions such as bladder cancer and prostate cancer often lead to significant changes in urinary function. Urodynamic testing plays a vital role in diagnosing these cancers, assessing their impact on bladder function, and monitoring the effectiveness of treatments. With the increasing incidence of urological cancers globally, there is a growing need for accurate diagnostic tools, including urodynamic devices. Additionally, advancements in technology that enhance the precision and comfort of these tests are further promoting the adoption of urodynamic assessments in oncology settings.

Benign Prostatic Hyperplasia:

Benign prostatic hyperplasia (BPH) is a common condition among older men, characterized by an enlarged prostate that can obstruct urinary flow. Urodynamic devices play a pivotal role in diagnosing the severity of BPH and in determining the appropriate treatment options. As the population ages, the prevalence of BPH is expected to rise, leading to increased demand for urodynamic assessments. The focus on improving patient outcomes through personalized treatment plans is further driving the adoption of urodynamic devices in the management of BPH. The awareness surrounding the condition and its impact on the quality of life is also contributing to the growth of this application segment.

Others:

The "Others" category encompasses various applications, including urinary tract infections and pelvic organ prolapse, where urodynamic devices are utilized for assessment and diagnosis. As awareness of these conditions grows, healthcare providers are increasingly employing urodynamic studies to better understand the underlying issues and guide treatment decisions. This broadening scope of applications is promoting the versatility and utility of urodynamic devices across different areas of urology. The ongoing research and development in this field are likely to unveil new applications, further contributing to market growth.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for urodynamic devices, largely due to their comprehensive healthcare services and advanced diagnostic capabilities. Most urodynamic testing is conducted in hospital settings where specialized urology departments are equipped with the necessary technology and staff trained in conducting these intricate assessments. The increasing number of urological procedures performed in hospitals, along with the rising focus on patient care quality, is driving the demand for advanced urodynamic devices. With hospitals continuously investing in cutting-edge technologies to enhance diagnostic accuracy, this segment is expected to maintain a strong growth trajectory in the market.

Clinics:

Urology clinics are becoming increasingly popular as distribution channels for urodynamic devices due to their specialized focus and ability to provide personalized care. As outpatient procedures gain traction, the demand for urodynamic assessments in clinic settings is on the rise. Clinics often offer more accessible and typically less expensive alternatives to hospital-based testing, which appeals to patients. The growing trend of patient-centered care, along with the increasing emphasis on preventative healthcare measures, is propelling the adoption of urodynamic devices in urology clinics. This segment is expected to see significant growth as more clinics incorporate advanced diagnostic technologies into their offerings.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as important venues for urodynamic testing, providing patients with a convenient and efficient alternative to hospitals. These centers are designed to facilitate outpatient procedures, making them an attractive option for patients who require urodynamic assessments but do not necessitate hospital admission. The increasing volume of minimally invasive surgeries and diagnostic procedures conducted in ASCs is contributing to the demand for urodynamic devices in these settings. As ASCs continue to expand their service offerings and improve patient experiences, the market for urodynamic devices in this channel is expected to grow significantly.

Home Care Settings:

Home care settings represent an evolving distribution channel for urodynamic devices, primarily driven by the growing trend of telehealth and remote patient monitoring. Patients with chronic urinary conditions may benefit from home-based assessments, which allow for greater comfort and convenience. Technological advancements have led to the development of portable and user-friendly devices that can be utilized in home environments, allowing patients to undergo testing without the need for frequent hospital visits. As healthcare providers increasingly adopt remote monitoring solutions to enhance patient care and reduce hospital visits, the demand for urodynamic devices in home care settings is anticipated to surge.

Others:

The "Others" category includes various distribution channels such as e-commerce platforms and specialty medical device suppliers. The growing trend of online purchasing has made urodynamic devices more accessible to healthcare providers and patients alike. E-commerce platforms offer the convenience of comparing products and prices, making it easier for clinics and hospitals to procure the necessary equipment. Additionally, specialty medical device suppliers that focus on urology are stepping up their offerings to cater to the specific needs of healthcare providers. This diversification of distribution channels is expected to enhance market reach and accessibility of urodynamic devices.

By Technology

Pressure Flow Studies:

Pressure flow studies are a critical technology used in urodynamic testing to assess bladder function and identify any abnormalities in urinary flow. This method measures the pressure inside the bladder while the patient is voiding, providing valuable insights into bladder compliance and outlet resistance. The increasing prevalence of urinary disorders and the growing demand for accurate diagnostic tools are driving the adoption of pressure flow studies in clinical practice. As advancements in technology enhance the precision and user experience of these studies, the segment is expected to witness significant growth.

Uroflowmetry:

Uroflowmetry is a pivotal technology in urodynamic assessments, primarily used to evaluate the flow rate of urine during voiding. It provides essential data for diagnosing conditions such as urinary obstruction and incontinence. The simplicity and non-invasive nature of uroflowmetry make it an attractive option for both patients and healthcare providers. With the increasing demand for efficient and accurate diagnostic methods, the adoption of advanced uroflowmetry devices is on the rise. As healthcare facilities aim to enhance patient care through accurate assessments, the uroflowmetry segment is expected to experience robust growth in the coming years.

Electromyography:

Electromyography (EMG) technology plays a vital role in assessing the neurological aspects of bladder function by measuring the electrical activity of pelvic floor muscles. This technology is crucial for diagnosing conditions related to muscle control and coordination. The growing recognition of the link between neurological disorders and bladder dysfunction is propelling the demand for electromyography devices in urodynamic assessments. As the healthcare landscape shifts towards more comprehensive diagnostic approaches, the adoption of EMG technology is expected to see significant growth as clinicians seek to enhance treatment strategies for patients with complex urinary conditions.

Cystometrogram:

The cystometrogram is an essential technology in urodynamic studies that measures bladder pressure and capacity, providing critical information regarding bladder function. This test is particularly useful in identifying conditions such as overactive bladder and bladder compliance issues. The increasing prevalence of urinary disorders and the need for accurate diagnostic tools are driving the demand for cystometrogram technology in clinical settings. As advancements in technology enhance the precision and efficiency of these tests, the cystometrogram segment is poised for substantial growth, contributing to the overall urodynamic devices market.

Others:

The "Others" category refers to various emerging technologies used in urodynamic assessments, such as biofeedback systems and advanced imaging techniques. These technologies are gaining traction as healthcare providers seek to enhance diagnostic accuracy and patient experiences. Innovations in urodynamic technology are making assessments more comfortable and efficient for patients, contributing to the growth of this segment. As the demand for comprehensive and personalized care increases, the adoption of diverse technologies in urodynamic testing is expected to accelerate, driving the overall market forward.

By Region

North America is anticipated to dominate the urodynamic devices market, accounting for a significant share of the global revenue. The region's advanced healthcare infrastructure, high prevalence of urinary disorders, and increasing awareness of urodynamic testing are key factors driving market growth. Furthermore, the presence of major players and continuous technological advancements in the region are contributing to its leadership position. The North American market is projected to grow at a CAGR of approximately 7.1% during the forecast period, driven by the rising demand for effective diagnostic and treatment solutions for urinary conditions.

Europe is another prominent region in the urodynamic devices market, characterized by a well-established healthcare system and growing emphasis on advanced urological diagnostics. The increasing prevalence of urinary disorders, coupled with a rising aging population, is fueling the demand for urodynamic devices across European countries. The European market is expected to experience steady growth, driven by ongoing innovations and research in urologic care. Additionally, countries like Germany and the UK are leading the adoption of urodynamic devices, further contributing to the regional market's expansion.

Opportunities

The urodynamic devices market presents numerous opportunities for growth, particularly through technological advancements and the integration of telehealth solutions. As digital health continues to evolve, the incorporation of remote monitoring technologies is becoming increasingly feasible. This trend allows for patients to undergo urodynamic assessments in the comfort of their homes, thereby improving patient compliance and satisfaction. Additionally, the development of portable and user-friendly urodynamic devices caters to the needs of both healthcare providers and patients, further enhancing market accessibility. Companies that innovate in this space stand to capture a significant share of the growing market as demand for convenient diagnostic solutions rises.

Moreover, the growing focus on preventive healthcare is fostering opportunities for urodynamic device manufacturers. With an increasing emphasis on early diagnosis and management of urinary disorders, healthcare providers are actively seeking effective diagnostic tools. The rising awareness surrounding urinary health and the importance of urodynamic testing are likely to drive growth in the market. Additionally, collaborations between device manufacturers and healthcare institutions can lead to enhanced training and education programs, further promoting the adoption of urodynamic devices. By capitalizing on these opportunities, stakeholders can position themselves for sustainable growth in the evolving urodynamics landscape.

Threats

Despite the promising growth prospects in the urodynamic devices market, several threats could impact development and sustainability. One significant threat is the increasing competition from alternative diagnostic methods, such as non-invasive imaging techniques that may offer simpler and less invasive solutions for assessing urinary function. Healthcare providers may prioritize these alternatives over traditional urodynamic assessments, which could hinder market growth. Furthermore, the rapid pace of technological advancements means that manufacturers must continually innovate to stay relevant. Failure to keep up with emerging technologies could lead to a loss of market share for existing players.

Another potential threat is regulatory challenges that could arise in different regions. The approval processes for medical devices can be lengthy and complex, which may delay the introduction of new products into the market. Additionally, stringent regulatory requirements can increase development costs and affect pricing strategies. Companies must navigate these challenges effectively to ensure compliance while maintaining competitiveness. Addressing these threats will require strategic planning and continuous adaptation to the evolving healthcare landscape.

Competitor Outlook

• Medtronic
• Boston Scientific
• Coloplast
• Cook Medical
• UROLOGIX
• CooperSurgical
• Laborie Medical Technologies
• Welch Allyn
• Hollister Incorporated
• Amecath
• Verathon
• Prometheus Medical
• Smiths Medical
• Alvimedica
• Neomedic International

The competitive landscape of the urodynamic devices market is characterized by a mix of well-established players and new entrants, all vying for market share through innovation and strategic collaborations. Major companies are increasingly investing in research and development to enhance their product offerings and stay ahead of emerging trends in urology. The focus on improving patient outcomes, coupled with the rising demand for advanced diagnostic solutions, is prompting companies to develop and launch new technologies tailored to meet the needs of healthcare providers and patients alike. Furthermore, acquisitions and partnerships between manufacturers and healthcare institutions are prevalent as companies seek to expand their reach and strengthen their position in the market.

Medtronic, one of the key players in the urodynamic devices market, has been at the forefront of innovation with its extensive portfolio of urological products. The company's commitment to advancing urodynamic testing technologies has positioned it as a leader in this space. Similarly, Boston Scientific is known for its comprehensive solutions in urology, focusing on enhancing patient care through innovative diagnostic and therapeutic devices. Their strategic investments in research and collaboration with healthcare professionals have contributed to their strong market presence.

In addition, Laborie Medical Technologies has established itself as a significant player in the market, specializing in urodynamics, pelvic floor assessment, and bladder health. The company is recognized for its commitment to quality and patient-centric solutions, further enhancing its competitive edge. As the market continues to evolve, these major players, along with emerging companies, will play a crucial role in shaping the future of urodynamic devices, ensuring that advancements in technology and patient care remain at the forefront of industry developments.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amecath
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 UROLOGIX
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Verathon
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Coloplast
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Alvimedica
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Welch Allyn
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cook Medical
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 CooperSurgical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Smiths Medical
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Boston Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Prometheus Medical
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hollister Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Neomedic International
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Laborie Medical Technologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Urodynamic Devices Market, By Technology
    • 6.1.1 Pressure Flow Studies
    • 6.1.2 Uroflowmetry
    • 6.1.3 Electromyography
    • 6.1.4 Cystometrogram
    • 6.1.5 Others
  • 6.2 Urodynamic Devices Market, By Application
    • 6.2.1 Urinary Incontinence
    • 6.2.2 Neurological Diseases
    • 6.2.3 Urological Cancer
    • 6.2.4 Benign Prostatic Hyperplasia
    • 6.2.5 Others
  • 6.3 Urodynamic Devices Market, By Product Type
    • 6.3.1 Uroflowmetry Equipment
    • 6.3.2 Cystometry Equipment
    • 6.3.3 Ambulatory Urodynamic Systems
    • 6.3.4 Electromyography Devices
    • 6.3.5 Video Urodynamic Systems
  • 6.4 Urodynamic Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Home Care Settings
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Urodynamic Devices Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Urodynamic Devices market is categorized based on

By Product Type

• Uroflowmetry Equipment
• Cystometry Equipment
• Ambulatory Urodynamic Systems
• Electromyography Devices
• Video Urodynamic Systems

By Application

• Urinary Incontinence
• Neurological Diseases
• Urological Cancer
• Benign Prostatic Hyperplasia
• Others

By Distribution Channel

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others

By Technology

• Pressure Flow Studies
• Uroflowmetry
• Electromyography
• Cystometrogram
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific
• Coloplast
• Cook Medical
• UROLOGIX
• CooperSurgical
• Laborie Medical Technologies
• Welch Allyn
• Hollister Incorporated
• Amecath
• Verathon
• Prometheus Medical
• Smiths Medical
• Alvimedica
• Neomedic International